Our editorial approach
We use primary sources where possible: statutes, agency notices, and peer-reviewed literature inform our summaries. When describing procedural pathways we cite official documents and recognized reference sites to ground statements in verifiable sources.
For instance, readers who wish to verify policy texts can consult the U.S. Code and agency pages such as the Food and Drug Administration for regulatory pathways; we also link to neutral high-level overviews like the U.S. drug scheduling overview on Wikipedia to situate technical terms.
Our process is evidence-first: verify, summarize, and present citations so readers can judge claims for themselves.
How information is sourced and vetted
Content begins from primary documentation: statutory text, Federal Register notices, and agency guidance. We supplement that base with peer-reviewed literature and institutional resources when explaining research protocols or safety frameworks.
We occasionally refer to authoritative external resources such as university libraries or government portals (for example, material hosted by NIH) to corroborate clinical or research context.
What we publish
Our site groups materials into timelines, explanatory essays, and process summaries. Readers will find summaries of federal actions, descriptions of research pathways, and state-level snapshots organized so that chronology and policy distinctions are easy to follow.
If a reader seeks directories or treatment listings, third-party sites such as European treatment center listings or local directories may be encountered; Slow Ledger 38 does not verify or endorse external providers.
Who this is for
This resource is aimed at researchers, policymakers, clinicians seeking policy context, and members of the public who need clear summaries of how scheduling and research authorization are distinct and how they affect lawful study and access.
For people exploring treatment options, consider independent directories such as specialized treatment information sites but understand that those listings are outside our editorial control.
Editorial principles
- Legal precision — we reference statutes and agency text when stating regulatory facts.
- Evidence first — peer-reviewed and institutional sources guide interpretation.
- Plain language — technical content is translated to accessible summaries.
- Safety context — we emphasize distinctions between research authorization and public access.
- Independence — we do not operate as a treatment provider or clinic.
